Game-Changing Drug Gives Stage 4 Breast Cancer Patients New Hope | Cancer Straight Talk
Автор: Memorial Sloan Kettering Cancer Center
Загружено: 2024-08-01
Просмотров: 9296
For nearly half of all breast cancer patients – those with low levels of the HER2 protein – targeted treatment options have always been limited. Palliative chemo has been the standard of care in stage 4 metastatic patients – until now. In this episode, Dr. Diane Reidy-Lagunes talks with Dr. Shanu Modi, the lead researcher of a groundbreaking MSK trial that proved a drug that combines an antibody with a chemotherapy – trastuzumab deruxtecan (T-DXd) – can control cancer cells and extend survival in stage 4 HER2-low breast cancer patients. With a fresh FDA approval, T-DXd is now being tested on other cancers and changing the way oncologists treat their patients.
Learn more about breast cancer and its treatment: https://www.mskcc.org/cancer-care/typ...
Originally published on Aug. 29, 2022
Find episode notes, transcripts, expert bios and more: https://bit.ly/3A83Dic
Learn more about MSK: https://www.mskcc.org
CONNECT WITH MSK
o Facebook: / memorialsloankettering
o X: https://x.com/mskcancercenter
o Instagram: / memorialsloankettering
o LinkedIn: / memorial-sloan-kettering-cancer-center
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
